Cargando…

Healthcare Costs And Resource Utilization In Chronic Pain Patients Treated With Extended-Release Formulations Of Tapentadol, Oxycodone, Or Morphine Stratified By Type Of Pain: A Retrospective Claims Analysis, 2012–2016

PURPOSE: Chronic pain treatment imposes a substantial economic burden on US society. Treatment costs may vary across subgroups of patients with different types of pain. The aim of our study was to compare healthcare costs (HC) and resource utilization in musculoskeletal (MP), neuropathic (NP), and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zah, Vladimir, Brookﬁeld, Rowe B, Imro, Martina, Tatovic, Simona, Pelivanovic, Jovana, Vukicevic, Djurdja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850678/ https://www.ncbi.nlm.nih.gov/pubmed/31819597 http://dx.doi.org/10.2147/JPR.S222617

Ejemplares similares

Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
por: Zah, Vladimir, et al.
Publicado: (2020)

A US Retrospective Claims Analysis Comparing Healthcare Costs of Patients Transitioning from Immediate-Release Oxycodone to Two Different Formulations of Extended-Release Oxycodone: Xtampza ER or OxyContin
por: Olatoke, Oluwadara, et al.
Publicado: (2022)

Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study
por: Morgan, Christopher Ll., et al.
Publicado: (2019)

Tapentadol shows lower intrinsic efficacy at µ receptor than morphine and oxycodone
por: Manandhar, Preeti, et al.
Publicado: (2022)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Tapentadol vs oxycodone/naloxone in the management of pain after total hip arthroplasty in the fast track setting: an observational study
por: D’Amato, Tiziana, et al.
Publicado: (2019)

A Randomized Controlled Trial on the Effect of Tapentadol and Morphine on Conditioned Pain Modulation in Healthy Volunteers
por: Martini, Chris, et al.
Publicado: (2015)

Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone
por: Haeseler, Gertrud, et al.
Publicado: (2017)

Quality of life under oxycodone/naloxone, oxycodone, or morphine treatment for chronic low back pain in routine clinical practice
por: Ueberall, Michael A, et al.
Publicado: (2016)

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
por: Nosek, Krzysztof, et al.
Publicado: (2017)

Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation
por: Zhou, Junxiang, et al.
Publicado: (2020)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
por: Durkin, Mike, et al.
Publicado: (2015)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Real-world Medicare Healthcare Costs of Patients with Dupuytren’s Contracture Treated with Collagenase or Fasciectomy
por: Zah, Vladimir, et al.
Publicado: (2022)

Web-Based Discussion and Illicit Street Sales of Tapentadol and Oxycodone in Australia: Epidemiological Surveillance Study
por: Black, Joshua, et al.
Publicado: (2021)

Molecular Mechanisms Underlying the Enhanced Analgesic Effect of Oxycodone Compared to Morphine in Chemotherapy-Induced Neuropathic Pain
por: Thibault, Karine, et al.
Publicado: (2014)

Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
por: Guo, Kai-Kai, et al.
Publicado: (2018)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Use of Oxycodone in Pain Management
por: Moradi, Mohammad, et al.
Publicado: (2012)

Epidural Oxycodone for Acute Pain
por: Piirainen, Panu, et al.
Publicado: (2022)

Influence of tapentadol and oxycodone on the spinal cord and brain using electrophysiology: a randomized, placebo‐controlled trial
por: Nedergaard, Rasmus Bach, et al.
Publicado: (2022)

Correction to: Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
por: Guo, Kai-Kai, et al.
Publicado: (2018)

Oxycodone is superior to morphine for pain relief following peroral oesophageal myotomy: a prospective, randomized, controlled trial
por: Xie, Guohao, et al.
Publicado: (2022)

Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations
por: Kibbe, AH, et al.
Publicado: (2018)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Comparison of the Risks of Shopping Behavior and Opioid Abuse Between Tapentadol and Oxycodone and Association of Shopping Behavior and Opioid Abuse
por: Cepeda, M. Soledad, et al.
Publicado: (2014)

Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
por: Bacallao, Jorge, et al.
Publicado: (2016)

Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study
por: Viñas-Bastart, Montserrat, et al.
Publicado: (2021)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uh3i8k2rkcijttntj881g63k35